34
ACKNOWLEDGEMENTS We are extremely grateful to the very wide range of individuals from clinical, academic and economic backgrounds - as well as representatives from the WHO, industry and NGOs - who have provided such extensive assistance and support during the preparation of this paper. The work of Chantal Morel and Elias Mossialos who have looked at the problem of antimicrobial resistance from a health economic perspective has been invaluable. As has the feedback and advice received from others listed below (in alphabetical order).
However, please note that the views and opinions expressed in this report represent those of the Review on Antimicrobial Resistance, and do not necessarily reflect those of the individuals and organisations named below. The Review has also engaged with many companies in preparing this report, and are grateful for their contribution, including from: Abbott, Alere, Biocartis, Biomerieux, Boots Walgreen, Cepheid, GSK, Hemocue, IBM Watson, MeMed, Merck, Philips Diagnostics,
QuantuMDx, Roche, Spectromics.
for Fungal Infections
Dr Manica Balasegeram, Médecins Sans Frontières Access Campaign
Dr Miles Denton, Lead Public Health Microbiologist, Public Health England
Owen Barder, Head of the Center for Global Development in Europe
Staff at the Department of Health Nicholas Gertler, Co-Founder at Galen/Atlantica
Mike Bonney, Former Chief Executive Officer, Cubist Pharmaceuticals Inc. Tobias Broger, Technical Officer, Foundation for Innovative New Diagnostics
Professor Herman Goossens, Professor of Medical Microbiology at the university Hospital of Antwerp Professor Kate Gould, Lead Public Health Microbiologist, Public Health England
Neil Butler, Chief Executive Officer Spectromics Dr Charles Clift, Senior Consulting Fellow, Centre on Global Health Security, Chatham House
Professor Carl Heneghan, Centre for Evidence-Based Medicine, Nuffield Department of Primary Care, University of Oxford
Professor Dame Sally Davies, UK Chief Medical Officer
Professor Richard Holliman, Lead Public Health Microbiologist, Public Health England
Carla Deakin, Associate Director - Diagnostics Assessment Programme, National Institute of Clinical and Health Excellent
Dr David Jenkins, Consultant Medical Microbiologist, University Hospitals of Leicester NHS Trust
Professor David Denning, President of the Global Action Fund
Dr Sue Kinn, Research Manager at Department for
